The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics
Open accessAbstract
Antimicrobial peptides (AMPs) are promising novel antibiotics since they have shown antimicrobial activity against a wide range of bacterial species, including multiresistant bacteria; however, toxicity is the major barrier to convert antimicrobial peptides into active drugs. A profound and proper understanding of the complex interactions between these peptides and biological membranes using biophysical tools and model membranes seems to be a key factor in the race to develop a suitable antimicrobial peptide therapy for clinical use. In the search for such therapy, different combined approaches with conventional antibiotics have been evaluated in recent years and demonstrated to improve the therapeutic potential of AMPs. Some of these approaches have revealed promising additive or synergistic activity between AMPs and chemical antibiotics. This review will give an insight into the possibilities that physicochemical tools can give in the AMPs research and also address the state of the art on the current promising combined therapies between AMPs and conventional antibiotics, which appear to be a plausible future opportunity for AMPs treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides
Chen, Y., Guarnieri, M. T., Vasil, A. I., Vasil, M. L., Mant, C. T., & Hodges, R. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-06 · Cited by 757
Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
Melo, M. N., Ferre, R., & Castanho, M. A. R. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2095 · Cited by 709
Ligand binding assays at equilibrium: validation and interpretation
Hulme, E. C., & Trevethick, M. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00604.x · Cited by 657
Toroidal pores formed by antimicrobial peptides show significant disorder
Sengupta, D., Leontiadou, H., Mark, A. E., & Marrink, S.-J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.06.007 · Cited by 563
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
Huang, S.-Y., Grinter, S. Z., & Zou, X. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp00151a · Cited by 508 · cited 1×
“Molecular docking programs through a cyclical evaluated ligand conformation by specific scoring functions until converging to a solution of minimum energy (Huang et al., 2010; Mulholland et al., 2016) have recently studied by docking the nisin2:lipid II complex in bacterial membranes, which has been put forward as the…”
BackgroundJiang, Z., Vasil, A. I., Hale, J. D., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2008) · Peptide Science · doi:10.1002/bip.20911 · Cited by 505
Zelezetsky, I., & Tossi, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.021 · Cited by 439
Yin, L. M., Edwards, M. A., Li, J., Yip, C. M., & Deber, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303602 · Cited by 423
Dathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W. L., MacDonald, D. L., Beyermann, M., & Bienert, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00055-0 · Cited by 409
Drug–protein binding: a critical review of analytical tools
Vuignier, K., Schappler, J., Veuthey, J.-L., Carrupt, P.-A., & Martel, S. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3737-1 · Cited by 389
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Host defense antimicrobial peptides as antibiotics: design and application strategies
Mishra, B., Reiling, S., Zarena, D., & Wang, G. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.03.014 · Cited by 299
Lin, L., Nonejuie, P., Munguia, J., Hollands, A., Olson, J., Dam, Q., Kumaraswamy, M., Rivera, H., Corriden, R., Rohde, M., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.021 · Cited by 278
Santos, N. C., Prieto, M., & Castanho, M. A. R. B. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00112-3 · Cited by 272
Hardy, G. J., Nayak, R., & Zauscher, S. (2013) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2013.06.004 · Cited by 243
Atomic force microscopy of supported lipid bilayers
Mingeot-Leclercq, M.-P., Deleu, M., Brasseur, R., & Dufrêne, Y. F. (2008) · Nature Protocols · doi:10.1038/nprot.2008.149 · Cited by 239
Alves, C. S., Melo, M. N., Franquelim, H. G., Ferre, R., Planas, M., Feliu, L., Bardají, E., Kowalczyk, W., Andreu, D., Santos, N. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.130955 · Cited by 233
Peptoids as potential therapeutics.
Zuckermann, R. N., & Kodadek, T. J. (2009) · PubMed · Cited by 225
De novo generation of short antimicrobial peptides with enhanced stability and cell specificity
Kim, H., Jang, J. H., Kim, S. C., & Cho, J. H. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt322 · Cited by 210
Antimicrobial peptides: an alternative for innovative medicines?
da Costa, J. P., Cova, M., Ferreira, R., & Vitorino, R. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6375-x · Cited by 206
Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!
Ghosh, C., Manjunath, G. B., Akkapeddi, P., Yarlagadda, V., Hoque, J., Uppu, D. S. S. M., Konai, M. M., & Haldar, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401680a · Cited by 205
Defensins: Natural component of human innate immunity
Jarczak, J., Kościuczuk, E. M., Lisowski, P., Strzałkowska, N., Jóźwik, A., Horbańczuk, J., Krzyżewski, J., Zwierzchowski, L., & Bagnicka, E. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.05.008 · Cited by 200
Hollmann, A., Martínez, M., Noguera, M. E., Augusto, M. T., Disalvo, A., Santos, N. C., Semorile, L., & Maffía, P. C. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.02.003 · Cited by 197
Self-citationAFM for structure and dynamics of biomembranes
Goksu, E. I., Vanegas, J. M., Blanchette, C. D., Lin, W.-C., & Longo, M. L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.021 · Cited by 196
Berglund, N. A., Piggot, T. J., Jefferies, D., Sessions, R. B., Bond, P. J., & Khalid, S. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004180 · Cited by 190
Bunker, A., Magarkar, A., & Viitala, T. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.02.025 · Cited by 190
Antimicrobial Peptides in Biomedical Device Manufacturing
Riool, M., de Breij, A., Drijfhout, J. W., Nibbering, P. H., & Zaat, S. A. J. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00063 · Cited by 189
Deleu, M., Crowet, J.-M., Nasir, M. N., & Lins, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.08.023 · Cited by 185
Function and therapeutic potential of host defence peptides
Mcphee, J. B., & Hancock, R. E. W. (2005) · Journal of Peptide Science · doi:10.1002/psc.704 · Cited by 182
Sakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176
Designing improved active peptides for therapeutic approaches against infectious diseases
Gomes, B., Augusto, M. T., Felício, M. R., Hollmann, A., Franco, O. L., Gonçalves, S., & Santos, N. C. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.004 · Cited by 172
Self-citationMembrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
van Rooijen, B. D., Claessens, M. M. A. E., & Subramaniam, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014292 · Cited by 161
Tamba, Y., & Yamazaki, M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8109622 · Cited by 158
The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
Fantini, J., Carlus, D., & Yahi, N. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.06.017 · Cited by 155
Role of helicity of α-helical antimicrobial peptides to improve specificity
Yi, H., He, L., Li, G., Zhai, N., Jiang, H., & Chen, Y. (2014) · Protein & Cell · doi:10.1007/s13238-014-0061-0 · Cited by 146
Emerging Themes and Therapeutic Prospects for Anti-Infective Peptides
Yount, N. Y., & Yeaman, M. R. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134535 · Cited by 143
The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
Boto, A., Pérez de la Lastra, J., & González, C. (2018) · Molecules · doi:10.3390/molecules23020311 · Cited by 136
Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides
Mihajlovic, M., & Lazaridis, T. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.016 · Cited by 134
How Many Antimicrobial Peptide Molecules Kill a Bacterium? The Case of PMAP-23
Roversi, D., Luca, V., Aureli, S., Park, Y., Mangoni, M. L., & Stella, L. (2014) · ACS Chemical Biology · doi:10.1021/cb500426r · Cited by 124
Synergistic Effects of Antimicrobial Peptides and Antibiotics against Clostridium difficile
Nuding, S., Frasch, T., Schaller, M., Stange, E. F., & Zabel, L. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02542-14 · Cited by 115
Solution and Micelle-Bound Structures of Tachyplesin I and Its Active Aromatic Linear Derivatives,
Laederach, A., Andreotti, A. H., & Fulton, D. B. (2002) · Biochemistry · doi:10.1021/bi026185z · Cited by 111
Membrane protein reconstitution into giant unilamellar vesicles: a review on current techniques
Jørgensen, I. L., Kemmer, G. C., & Pomorski, T. G. (2016) · European Biophysics Journal · doi:10.1007/s00249-016-1155-9 · Cited by 110
Maturana, P., Martínez, M. M. B., Noguera, M. E., Santos, N. C., Disalvo, E. A., Semorile, L., Maffía, P. C., & Hollmann, A. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.02.003 · Cited by 109
Self-citationLewies, A., Wentzel, J. F., Jordaan, A., Bezuidenhout, C. C., & Plessis, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.071 · Cited by 97
Hawrani, A., Howe, R. A., Walsh, T. R., & Dempsey, C. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709154200 · Cited by 93
Membrane–drug interactions studied using model membrane systems
Knobloch, J. J., Suhendro, D. K., Zieleniecki, J. L., Shapter, J. G., & Köper, I. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2015.03.007 · Cited by 91
Quantitative assessment of peptide–lipid interactions.
Matos, P. M., Franquelim, H. G., Castanho, M. A. R. B., & Santos, N. C. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.07.012 · Cited by 83
Feng, Q., Huang, Y., Chen, M. W., Li, G., & Chen, Y. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2219-3 · Cited by 81
Huo, L., Zhang, K., Ling, J., Peng, Z., Huang, X., Liu, H., & Gu, L. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2011.02.004 · Cited by 77
Jobin, M., Bonnafous, P., Temsamani, H., Dolé, F., Grélard, A., Dufourc, É. J., & Alves, I. D. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.02.008 · Cited by 75
Dengue virus capsid protein interacts specifically with very low-density lipoproteins
Faustino, A. F., Carvalho, F. A., Martins, I. C., Castanho, M. A. R. B., Mohana‐Borges, R., Almeida, F. C. L., Poian, A. T. D., & Santos, N. C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.004 · Cited by 70
Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes
Tiriveedhi, V., Kitchens, K. M., Nevels, K. J., Ghandehari, H., & Butko, P. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.08.017 · Cited by 70
Islas-Rodríguez, A. E., Marcellini, L., Orioni, B., Barra, D., Stella, L., & Mangoni, M. L. (2009) · Journal of Peptide Science · doi:10.1002/psc.1148 · Cited by 70
In silico pharmacology: Drug membrane partitioning and crossing
Meo, F. D., Fabre, G., Berka, K., Ossman, T., Chantemargue, B., Paloncýová, M., Marquet, P., Otyepka, M., & Trouillas, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.030 · Cited by 69
Membrane thickness and the mechanism of action of the short peptaibol trichogin GA IV
Bobone, S., Gerelli, Y., Zotti, M. D., Bocchinfuso, G., Farrotti, A., Orioni, B., Sebastiani, F., Latter, E., Penfold, J., Senesi, R., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.11.033 · Cited by 65
Savini, F., Luca, V., Bocedi, A., Massoud, R., Park, Y., Mangoni, M. L., & Stella, L. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00910 · Cited by 62
Structure and Biological Functions of β-Hairpin Antimicrobial Peptides
Panteleev, P. V., Bolosov, I. A., Баландин, С. В., & Ovchinnikova, T. V. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-1-37-47 · Cited by 61
Faccone, D. F., Véliz, O., Corso, A. C., Noguera, M. E., Martínez, M. M. B., Payés, C., Semorile, L., & Maffía, P. C. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.065 · Cited by 59
Self-citationEffect of lipopeptides and iontophoresis on aciclovir skin delivery
Nicoli, S., Eeman, M., Deleu, M., Bresciani, E., Padula, C., & Santi, P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.06.0006 · Cited by 58
Identification and Design of Antimicrobial Peptides for Therapeutic Applications
Ahmad, A., Ahmad, E., Rabbani, G., Haque, S., Arshad, M., & Khan, R. H. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312800785076 · Cited by 56
He, J., Starr, C. G., & Wimley, W. C. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.09.010 · Cited by 55
Using fluorescence for studies of biological membranes: a review
Kyrychenko, A. V. (2015) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/3/4/042003 · Cited by 52
Bessa, L. J., Eaton, P. J., Dematei, A., Plácido, A., Vale, N., Gomes, P. A. C., Delerue-Matos, C. M., Leite, J. R. S. A., & Gameiro, P. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0175 · Cited by 52
Fernandes, M. X., de la Torre, J. G., & Castanho, M. A. R. B. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00024-6 · Cited by 51
Savini, F., Bobone, S., Roversi, D., Mangoni, M. L., & Stella, L. (2018) · Peptide Science · doi:10.1002/pep2.24041 · Cited by 50
A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders
Kountouras, J., Deretzi, G., Gavalas, E., Zavos, C., Pοlyzos, S. A., Kazakos, E. I., Giartza‐Taxidou, E., Vardaka, E., Kountouras, C., Katsinelos, P., et al. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2013.12.025 · Cited by 43
MONOTHERAPY VERSUS COMBINATION THERAPY FOR BACTERIAL INFECTIONS
Bouza, E., & Muñóz, P. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70293-5 · Cited by 40
Malgieri, G., Avitabile, C., Palmieri, M., D’Andrea, L. D., Isernia, C., Romanelli, A., & Fattorusso, R. (2015) · ACS Chemical Biology · doi:10.1021/cb501057d · Cited by 39
Do we really need new anti-infective drugs?
Rice, L. B. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.05.001 · Cited by 31
Docking and molecular dynamics simulations of the ternary complex nisin2:lipid II
Mulholland, S., Turpin, E. R., Bonev, B. B., & Hirst, J. D. (2016) · Scientific Reports · doi:10.1038/srep21185 · Cited by 23
Lyu, Y., Domalaon, R., Yang, X., & Schweizer, F. (2017) · Peptide Science · doi:10.1002/bip.23091 · Cited by 22
Knobloch, J. J., Nelson, A. R. J., Köper, I., James, M., & McGillivray, D. J. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02458 · Cited by 16
Segev-Zarko, L.-A. T., Kapach, G., Josten, M., Klug, Y. A., Sahl, H., & Shai, Y. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00149 · Cited by 16
Bouchet, A. M., Iannucci, N. B., Pastrián, M. B., Cascone, O., Santos, N. C., Disalvo, E. A., & Hollmann, A. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.10.025 · Cited by 13
Self-citationBhosale, J. D., Dabur, R., Jadhav, G. P., & Bendre, R. S. (2018) · Molecules · doi:10.3390/molecules23040875 · Cited by 11
How a short pore forming peptide spans the lipid membrane
Vestergaard, M., Christensen, M. H., Hansen, S. K., Grønvall, D., Kjølbye, L. R., Vosegaard, T., & Schiøtt, B. (2017) · Biointerphases · doi:10.1116/1.4982642 · Cited by 7
Cited by
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Insect Antimicrobial Peptides, a Mini Review
Wu, Q., Patočka, J., & Kuča, K. (2018) · Toxins · doi:10.3390/toxins10110461 · Cited by 481
Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms
Benfield, A. H., & Henriques, S. T. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.610997 · Cited by 367
Metadata
- Authors
- Hollmann, A., Martinez, M., Maturana, P., Semorile, L. C., & Maffia, P. C.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2018-06-05
- Volume
- 6
- Pages
- 204-204
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W2804562858
- Cited by
- 334
- References
- 84
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.